Sana Biotechnology (SANA) Announces CFO Resignation

On September 6, 2024, Nathan Hardy notified Sana Biotechnology (NASDAQ: SANA) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024. Mr. Hardy resigned voluntarily for personal reasons and not as a result of any disagreement with the Company on any matter, including related to the Company’s operations, policies, practices or otherwise.

You May Also Be Interested In

• Destination XL Group names Jimmy Olsson as chief growth officer
• CDW to acquire data and AI firm Lovelytics for $525 million
• Coinbase expands board to ten with appointment of Anthony Armstrong